AAAAAA

   
Results: 1-7 |
Results: 7
Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults
Authors: Martin, TG Gajewski, JL
Citation: Tg. Martin et Jl. Gajewski, Allogeneic stem cell transplantation for acute lymphocytic leukemia in adults, HEMAT ONCOL, 15(1), 2001, pp. 97
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer
Authors: Donato, ML Gershenson, DM Wharton, JT Ippoliti, CM Aleman, AS Bodurka-Bevers, D Bevers, MW Burke, TW Levenback, CF Wolf, JK Freedman, RS Bast, RC Gajewski, JL Champlin, RE
Citation: Ml. Donato et al., High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: A new regimen for the treatment of advanced ovarian cancer, GYNECOL ONC, 82(3), 2001, pp. 420-426
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
Authors: Gopal, R Ha, CS Tucker, SL Khouri, IF Giralt, SA Gajewski, JL Andersson, BS Cox, JD Champlin, RE
Citation: R. Gopal et al., Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity, CANCER, 92(7), 2001, pp. 1949-1958
Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality
Authors: Khouri, IF Saliba, RM Giralt, SA Lee, MS Okoroji, GJ Hagemeister, FB Korbling, M Younes, A Ippoliti, C Gajewski, JL McLaughlin, P Anderlini, P Donato, ML Cabanillas, FF Champlin, RE
Citation: If. Khouri et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, BLOOD, 98(13), 2001, pp. 3595-3599
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
Authors: Hortobagyi, GN Buzdar, AU Theriault, RL Valero, V Frye, D Booser, DJ Holmes, FA Giralt, S Khouri, I Andersson, B Gajewski, JL Rondon, G Smith, TL Singletary, SE Ames, FC Sneige, N Strom, EA McNeese, MD Deisseroth, AB Champlin, RE
Citation: Gn. Hortobagyi et al., Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma, J NAT CANC, 92(3), 2000, pp. 225-233
Long-term outcome of a Phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients
Authors: Gajewski, JL Nimer, S Saliba, RM Thomas, M Przepiorka, D Giralt, S von Besien, K Mehra, R Andersson, B Chan, KW Ippoliti, C Warkinten, D Feig, S Territo, M Schiller, G Lebkowski, J Moseley, AM Lloyd, K von Hoeff, M Okarma, T Champlin, R
Citation: Jl. Gajewski et al., Long-term outcome of a Phase II study of BM transplants, partially depleted ex-vivo of CD5-positive and CD8-positive T-lymphocytes in unrelated and related donor 1 antigen mismatched recipients, CYTOTHERAPY, 1(5), 1999, pp. 401-407
Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry
Authors: Lazarus, HM Rowlings, PA Zhang, MJ Vose, JM Armitage, JO Bierman, PJ Gajewski, JL Gale, RP Keating, A Klein, JP Miller, CB Phillips, GL Reece, DE Sobocinski, KA van Besien, K Horowitz, MM
Citation: Hm. Lazarus et al., Autotransplants for Hodgkin's disease in patients never achieving remission: A report from the autologous blood and marrow transplant registry, J CL ONCOL, 17(2), 1999, pp. 534-545
Risultati: 1-7 |